UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030506
Receipt number R000034352
Scientific Title A reserch of swallowing pressure mesured by high resolution manometory after chemoradiotherapy for patients with head and neck cancer
Date of disclosure of the study information 2018/03/31
Last modified on 2020/06/28 13:33:30

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A reserch of swallowing pressure mesured by high resolution manometory after chemoradiotherapy for patients with head and neck cancer

Acronym

A reserch of swallowing pressure mesured by high resolution manometory after chemoradiotherapy for patients with head and neck cancer

Scientific Title

A reserch of swallowing pressure mesured by high resolution manometory after chemoradiotherapy for patients with head and neck cancer

Scientific Title:Acronym

A reserch of swallowing pressure mesured by high resolution manometory after chemoradiotherapy for patients with head and neck cancer

Region

Japan


Condition

Condition

head and neck cancer

Classification by specialty

Oto-rhino-laryngology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To detect of changing swallowing pressure after chemoradiotherapy for patients with head and neck cancer

Basic objectives2

Others

Basic objectives -Others

To evaluate the correlation with swallowing pressure and common test of swallowing function

Trial characteristics_1

Exploratory

Trial characteristics_2

Explanatory

Developmental phase



Assessment

Primary outcomes

Evaluation for swallowing pressure at 3 and 12 months after chemoradiotherapy. Calcurate the rate of changing in these two times.

Key secondary outcomes

To evaluate the correlation with swallowing pressure and common test of swallowing function


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

twaice high resolution manometory

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Over 20 year-old
no recurrent of head and neck cancer
patients with consent by paper

Key exclusion criteria

patients with dysphagia before having a head and neck cancer
having past history of other head and neck cancer and advanced esophageal cancer
allergic for local anesthesis
pregnancy
having a severe cardiovascular disease
uncontrolled hepatitis B virus
evaluated for exclude by reserch docter

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Ken-ichi
Middle name
Last name nibu

Organization

Kobe university graduate school of medicine

Division name

department of Otolaryngology-head and neck surgery

Zip code

6500017

Address

Hyogo, kobe, tyuuouku, kusunokityou,7-5-2

TEL

078-382-6024

Email

nibu@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name Tatsuya
Middle name
Last name Furukawa

Organization

Kobe university graduate school of medicine

Division name

department of Otolaryngology-head and neck surgery

Zip code

6500017

Address

Hyogo, kobe, tyuuouku, kusunokityou,7-5-2

TEL

078-382-6024

Homepage URL


Email

ftatsuya@med.kobe-u.ac.jp


Sponsor or person

Institute

Kobe university graduate school of medicine, department of Otolaryngology-head and neck surgery

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Clinical Research Ethical Committee

Address

7-5-2, Kusunoki-cho, Chuo-ku, Kobe , Japan

Tel

078-382-6669

Email

cerb@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

神戸大学病院(兵庫県)、東京大学(東京都)、名古屋大学(愛知県)


Other administrative information

Date of disclosure of the study information

2018 Year 03 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2017 Year 11 Month 22 Day

Date of IRB

2018 Year 03 Month 29 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 21 Day

Last modified on

2020 Year 06 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034352


Research Plan
Registered date File name
2023/07/01 C180094_PRT_v9.1_20230205.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name